Table 4 Effect of adherence on 12-month changes (Δ) in anthropometric, hepatic, and cardiometabolic indicators among children with MetS (GEE model; n = 300).
Δ Indicator | Effect size (β) | 95% CI | p-value |
|---|---|---|---|
Δ Weight (kg) | –2.01 | –2.45 to − 1.56 | < 0.001 |
Δ Height (cm) | + 0.96 | + 0.55 to + 1.37 | < 0.001 |
Δ BMI (kg/m²) | –1.04 | –1.19 to − 0.90 | < 0.001 |
Δ Waist circumference (cm) | –1.74 | –2.27 to − 1.20 | < 0.001 |
Δ Hip circumference (cm) | –0.71 | –1.06 to − 0.36 | < 0.001 |
Δ Systolic BP (mmHg) | –1.29 | –2.35 to − 0.24 | 0.017 |
Δ Diastolic BP (mmHg) | –0.55 | –1.31 to + 0.22 | 0.163 |
Δ WHR | –0.01 | –0.02 to − 0.01 | < 0.001 |
Δ WHtR | –0.01 | –0.02 to − 0.01 | < 0.001 |
Δ Fasting glucose (mg/dL) | –0.07 | –0.16 to + 0.02 | 0.143 |
Δ ALT (U/L) | –1.24 | –3.36 to + 0.89 | 0.254 |
Δ AST (U/L) | –0.89 | –1.88 to + 0.10 | 0.079 |
Δ HbA1c (%) | –0.08 | –0.14 to − 0.02 | 0.010 |
Δ CAP (dB/m) | –7.65 | –13.10 to − 2.20 | 0.006 |
Δ Triglycerides (mmol/L) | –0.42 | –0.55 to − 0.29 | < 0.001 |
Δ HDL-C (mmol/L) | + 0.06 | + 0.03 to + 0.09 | < 0.001 |
